NCT07099469

Brief Summary

This is a pilot study in which a total of 6 people will participate. This study aims to optimize the postoperative pain management of an anatomically minimally invasive lung resection (RATS) by comparing 2 pain-relieving techniques. As standard, an intercostal block is placed at the end of the procedure by injecting a local anesthetic at the site where the patient will be operated on. This study compares the previous method with the use of cryotherapy as an intercostal block. This technique uses cryo probes and blocks postoperative pain for 1-3 months. By comparing both techniques, it is examined whether cryotherapy requires less pain medication and is therefore more effective.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
6

participants targeted

Target at below P25 for all trials

Timeline
6mo left

Started Mar 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress70%
Mar 2025Nov 2026

First Submitted

Initial submission to the registry

March 21, 2025

Completed
4 days until next milestone

Study Start

First participant enrolled

March 25, 2025

Completed
4 months until next milestone

First Posted

Study publicly available on registry

August 1, 2025

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2026

Last Updated

May 6, 2026

Status Verified

April 1, 2026

Enrollment Period

1.4 years

First QC Date

March 21, 2025

Last Update Submit

April 30, 2026

Conditions

Keywords

C-ICNBR-ICNBRATS Surgerypostoperative pain

Outcome Measures

Primary Outcomes (1)

  • The NRS pain score

    The NRS score will be used to measure pain scores and this will be the primary outcome of the study.

    Baseline, post-operative (day 0) in the recoveryward when the patient is awake and after 6 hours. Day 1-2-3 the NRS wil be measured in the morning, afternoon and evening. During the Follow-up visits: 2 weeks and 12 weeks after surgery

Secondary Outcomes (8)

  • QoR-15 questionnaire

    Measured at baseline, post-operative after surgery day 0, day 1, day 2 day 3 and day 4 during hospitalisation. At Folluw-up visit after 2 weeks and after 12 weeks

  • Lenght of stay

    From date of hospitalization until discharge, estimated time of hospitalisation is 5 days, but we will measure until discharge from the hospital.

  • Use of pain medication

    during the postopertieve hospotalization periode, day 0 till day 3

  • Pain during mobilization

    During the postopertieve hospotalization periode, day 0 till day 3

  • Patient satisfaction

    During post-opertieve periode day 0 - day 3.

  • +3 more secondary outcomes

Study Arms (2)

R-ICNB

At the end of the procedure, an intercostal block is placed by injecting a local anesthetic into the site of surgery.

C-ICNB

At the end of the surgery single shot cryotherapy will be placed at 6 levels (T3-T8) with the AtriCure"s cryoICE cryosphere cryoablation probes.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients referred for anatomical lung resection (lobectomy or segmentectomy) with the intention of performing it by robotic-assisted thoracoscopic surgery (RATS) are eligible for the trial.

You may qualify if:

  • Adult patients of 18 years or older who are able to give informed consent and fill out questionnaires in Dutch.

You may not qualify if:

  • Patients who need an anatomic resection of the lung that's larger than one lung lobe, who have CPAM or infections.
  • Patients with chronic use (\>3 months) of strong opioids because of co-morbidities -for example, the use of tramadol is allowed.
  • If there's a high risk of conversion to a thoracotomy. This will be evaluated by the lung surgeon.
  • Patients who have had thoracic surgery in the past.
  • Patients with chronic kidney disease stage 4 or 5 (GFR \< 30 mL/min)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Antwerp

Edegem, Antwerp, 2560, Belgium

Location

MeSH Terms

Conditions

Pain, Postoperative

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Study Officials

  • Prof. J. Hendriks, MD. PhD.

    University Hospital, Antwerp

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof. Dr. J. Hendriks

Study Record Dates

First Submitted

March 21, 2025

First Posted

August 1, 2025

Study Start

March 25, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

November 1, 2026

Last Updated

May 6, 2026

Record last verified: 2026-04

Locations